BioNTech
Develops personalized immunotherapies with a focus on cancer medicine. Learn more
Launch date
Employees
Market cap
AUD45.3b
Enterprise valuation
AUD16.4b (Public information from Sep 2024)
Share price
$112.51 BNTX
Company register number HRB 48720 (Mainz)
Mainz Rhineland-Palatinate (HQ)
Authorizing premium user...